CS1-SPECIFIC SINGLE-DOMAIN ANTIBODIES LABELED WITH ACTINIUM-225 PROLONG SURVIVAL AND INCREASE CD8+ T CELLS AND PD-L1 EXPRESSION IN MULTIPLE MYELOMA

CS1-specific single-domain antibodies labeled with Actinium-225 prolong survival and increase CD8+ T cells and PD-L1 expression in Multiple Myeloma

Multiple myeloma (MM) is a hematological malignancy characterized by the presence of clonal plasma cells in the bone marrow niche.Despite significant therapeutic advances, MM remains incurable for the majority of patients.Targeted radionuclide therapy (TRNT) has emerged as a promising treatment option to eradicate residual cancer cells.In this stud

read more




Acceptability of an mHealth App That Provides Harm Reduction Services Among People Who Inject Drugs: Survey Study

BackgroundHarm reduction services reduce the negative consequences of drug injection and are often embedded within syringe service programs (SSPs).However, people who inject drugs (PWID) suboptimally engage with such services because of stigma, fear, transportation restrictions, and limited hours of operation.Mobile health (mHealth) apps may Vitami

read more